• MSD chalks up two HIV drug approvals in Europe pharmafile
    December 03, 2018
    MSD has announced the European approval of two of its products for the treatment of HIV: the single-tablet combination Delstrigo (doravirine, lamivudine and tenofovir disoproxil fumarate)
PharmaSources Customer Service